Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial

Abstract Aims Iron deficiency (ID) is associated with an impaired cardiac function and remodelling in heart failure (HF). Treatment with ferric carboxymaltose (FCM) has been showed recently to improve biventricular systolic function and ventricular strain parameters in patients with HF with reduced...

Full description

Bibliographic Details
Main Authors: Enrique Santas, Irene delCanto, Ingrid Cardells, Gema Miñana, Pau Llàcer, Luis Almenar, Lorenzo Fácila, Alicia M. Maceira, Juan Sanchis, Julio Núñez, Myocardial‐IRON Investigators
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:ESC Heart Failure
Subjects:
Heart failure
Iron deficiency
Ferric carboxymaltose
Cardiovascular magnetic resonance
Feature tracking
Left atrial
Online Access:https://doi.org/10.1002/ehf2.14630

Internet

https://doi.org/10.1002/ehf2.14630

Similar Items